From: Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
 | 177Lu activity concentration (%IA/g) | ||||||
---|---|---|---|---|---|---|---|
0.15 MBq | 15 MBq | ||||||
Time p.i. | 1 h | 24 h | 48 h | 168 h | 1 h | 24 h | 168 h |
 Adrenals | 27 (7) | 14 (2) | 13 (2) | 5.2 (0.7) | 5.5 (1.2) | 1.5 (0.1) | 0.63 (0.11) |
 Blood | 3.1 (1.0) | 0.35 (0.11) | 0.16 (0.02) | 0.11 (0.04) | 1.5 (0.6) | 0.044 (0.005) | 0.014 (0.002) |
 Brain | 0.33 (0.05) | 0.19 (0.07) | 0.17 (0.06) | 0.045 (0.002) | 0.33 (0.10) | 0.084 (0.020) | 0.019 (0.002) |
 Kidneys | 59 (7) | 25 (2) | 12 (2) | 1.6 (0.2) | 37 (2) | 15 (1) | 1.2 (0.2) |
 Liver | 5.7 (0.6) | 1.2 (0.1) | 1.2 (0.1) | 0.60 (0.06) | 1.3 (0.1) | 0.42 (0.04) | 0.11 (0.01) |
 Lungs | 90 (15) | 35 (3) | 27 (4) | 8.7 (1.0) | 6.4 (0.8) | 1.4 (0.1) | 0.49 (0.03) |
 Spleen | 8.5 (1.2) | 2.8 (0.1) | 2.9 (0.4) | 1.2 (0.1) | 1.3 (0.2) | 0.31 (0.02) | 0.16 (0.01) |
 Tumor | 50 (14) | 34 (3) | 54 (19) | 5.0 (1.1) | 27 (7) | 12 (1) | 33 (8) |
Tumor-to-normal-tissue concentration ratio (T/N) | |||||||
T/N | 1 h | 24 h | 48 h | 168 h | 1 h | 24 h | 168 h |
 Adrenals | 6.7 (4.7) | 2.7 (0.3) | 3.8 (0.7) | 0.96 (0.15) | 4.7 (0.2) | 8.2 (0.7) | 34 (11) |
 Blood | 25 (11) | 180 (71) | 320 (62) | 72 (23) | 21 (3) | 520 (160) | 2800 (970) |
 Brain | 200 (70) | 270 (66) | 400 (130) | 110 (24) | 89 (12) | 170 (28) | 1800 (470) |
 Kidneys | 0.93 (0.24) | 1.4 (0.1) | 4.6 (1.1) | 3.1 (0.4) | 0.69 (0.13) | 0.80 (0.06) | 24 (8) |
 Liver | 9.3 (2.2) | 28 (3) | 45 (13) | 8.0 (1.0) | 20 (4) | 29 (2) | 220 (73) |
 Lungs | 0.62 (0.16) | 0.99 (0.10) | 2.1 (0.5) | 0.57 (0.08) | 4.0 (0.5) | 8.5 (0.3) | 66 (15) |
 Spleen | 6.8 (1.8) | 12 (1.4) | 20 (5.8) | 4.2 (0.6) | 20 (2) | 39 (2) | 150 (56) |